DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load
Demethylation of the genome is found in cancer. Here, the authors show that genomic demethylation entails changes in promoter methylation and gene expression associated with immune escape and suggest that the epigenetic alterations may be an important determinant of responses to immunotherapy.
Guardado en:
Autores principales: | Hyunchul Jung, Hong Sook Kim, Jeong Yeon Kim, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Manel Esteller, Se-Hoon Lee, Jung Kyoon Choi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/85658e71ba8442669c3d3515dd6416cb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Predicting clinical benefit of immunotherapy by antigenic or functional mutations affecting tumour immunogenicity
por: Kwoneel Kim, et al.
Publicado: (2020) -
Copy number rather than epigenetic alterations are the major dictator of imprinted methylation in tumors
por: Alex Martin-Trujillo, et al.
Publicado: (2017) -
Assessment of copy number in protooncogenes are predictive of poor survival in advanced gastric cancer
por: Meihui Li, et al.
Publicado: (2021) -
Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder
por: Dong Hyeon Lee, et al.
Publicado: (2018) -
Copy number-dependent DNA methylation of the Pyricularia oryzae MAGGY retrotransposon is triggered by DNA damage
por: Ba Van Vu, et al.
Publicado: (2021)